Drug Shortage Report for LIDOCAINE HYDROCHLORIDE INJECTION USP

Last updated on 2024-04-09 History
Report ID 207619
Drug Identification Number 02422018
Brand name LIDOCAINE HYDROCHLORIDE INJECTION USP
Common or Proper name LIDOCAINE HYDROCHLORIDE INJECTION USP
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) LIDOCAINE HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration BLOCK/INFILTRATION BLOCK/INFILTRATION
Packaging size 50mL
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2023-11-01
Actual start date
Estimated end date 2024-03-31
Actual end date 2024-04-08
Shortage status Resolved
Updated date 2024-04-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2024-04-09 French Compare
v10 2024-04-09 English Compare
v9 2024-03-01 French Compare
v8 2024-03-01 English Compare
v7 2024-02-06 French Compare
v6 2024-02-06 English Compare
v5 2023-12-18 French Compare
v4 2023-12-18 English Compare
v3 2023-11-02 English Compare
v2 2023-10-20 French Compare
v1 2023-10-20 English Compare

Showing 1 to 11 of 11